Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating osteoproliferation and preparation method thereof

A technology for bone hyperplasia and composition, which can be used in drug combinations, pharmaceutical formulations, medical preparations containing active ingredients, etc.

Inactive Publication Date: 2017-05-17
JINAN HAOYU QINGTIAN PHARMA TECH CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, for mild bone hyperplasia and severe bone hyperplasia, acupuncture and moxibustion therapy has a good effect, but it still cannot be used as the primary treatment for bone hyperplasia.
Massage therapy is roughly the same as acupuncture therapy, which can also relieve pain, promote blood circulation and remove blood stasis, but it is still not the first choice for bone hyperplasia treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Embodiment 1: the pharmaceutical composition for the treatment of hyperosteogeny and preparation method thereof

[0035] The composition and parts by weight of the raw material drug of the pharmaceutical composition for treating hyperosteogeny are: Xiaoerxiancao 467g Dajindao 325g Coreopsis 26g Salted Shrimp Flower 256g β-amyresin acetate 3g;

[0036] Preparation:

[0037] (1) According to the ratio of raw materials, take Xiaoerxiancao, Dajindao, coreopsis oh, salted shrimp flower, β-amyresin alcohol acetate, mix well, use ethanol with a concentration of 23.5% by weight as a solvent, and mix it at 33.5 ℃ warm immersion extraction, the number of extractions is 24 times, each extraction time is 56 hours, and the amount of solvent used each time is 49 times the total weight of the raw material drug, filtered to obtain medicinal residue A and extract A, extract A recovers ethanol, concentrates To a relative density of 1.04, filter, the drug solution passes through the LKS0...

Embodiment 2

[0040] Embodiment 2: the pharmaceutical composition for the treatment of hyperosteogeny and preparation method thereof

[0041] The composition and parts by weight of the raw material drug of the pharmaceutical composition for treating hyperosteogeny are: Xiaoerxiancao 465g Dajindao 330g Coreopsis 24g Salted Shrimp Flower 258g β-amyresin acetate 2g;

[0042] Preparation:

[0043] (1) According to the ratio of raw materials, take Xiaoerxiancao, Dajindao, coreopsis oh, salted shrimp flower, β-amyresin alcohol acetate, mix well, use ethanol with a concentration of 23.5% by weight as a solvent, and mix it at 33.5 ℃ warm immersion extraction, the number of extractions is 24 times, each extraction time is 56 hours, and the amount of solvent used each time is 49 times the total weight of the raw material drug, filtered to obtain medicinal residue A and extract A, extract A recovers ethanol, concentrates To a relative density of 1.04, filter, the drug solution passes through the LKS0...

Embodiment 3

[0046] Embodiment 3: the pharmaceutical composition for the treatment of hyperosteogeny and preparation method thereof

[0047] The composition and parts by weight of the raw materials of the pharmaceutical composition for treating hyperosteogeny are: Xiaoerxiancao 469g Dajindao 320g Coreopsis 28g Salted Shrimp Flower 254g β-amyresin acetate 4g;

[0048] Preparation:

[0049] (1) According to the ratio of raw materials, take Xiaoerxiancao, Dajindao, coreopsis oh, salted shrimp flower, β-amyresin alcohol acetate, mix well, use ethanol with a concentration of 23.5% by weight as a solvent, and mix it at 33.5 ℃ warm immersion extraction, the number of extractions is 24 times, each extraction time is 56 hours, and the amount of solvent used each time is 49 times the total weight of the raw material drug, filtered to obtain medicinal residue A and extract A, extract A recovers ethanol, concentrates To a relative density of 1.04, filter, the drug solution passes through the LKS02 ma...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating osteoproliferation and a preparation method thereof. The pharmaceutical composition is prepared by proportioning haloragis micrantha, neolepisorus, maritimetin, vernonia patula and beta-amyrin acetate as raw material medicines, can be prepared into various forms according to a conventional preparation process, and is remarkable in curative effect for treating osteoproliferation.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to a pharmaceutical composition for treating hyperosteogeny and a preparation method thereof. Background technique [0002] Osteoarthritis, commonly known as bone spur, is a disease often suffered by middle-aged and elderly people. It is mainly a common physiological phenomenon caused by the aging of the joints of elderly patients. The older the patient, the higher the prevalence rate. In China, the aggravation of the aging society has led to an increase in the prevalence of the disease year by year. During the onset period, patients with hyperosteogeny mainly manifest as pain and numbness in the joints, which seriously affect the daily life of patients with hyperosteogeny. The essence of osteoproliferative lesions is due to specific lesions on the articular surface or edges. The proliferative bone spurs compress the surrounding soft tissues, nerv...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/28A61P19/08A61K31/343A61K31/56
CPCA61K36/28A61K31/343A61K31/56A61K36/11A61K36/185A61K2236/333A61K2236/39A61K2236/51A61K2236/55
Inventor 不公告发明人
Owner JINAN HAOYU QINGTIAN PHARMA TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com